World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
23397
World Ranking
15211
National Ranking
579

Philip M. Kluin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip M. Kluin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 281 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philip M. Kluin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip M. Kluin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip M. Kluin is affiliated with the University Medical Center Groningen in the Netherlands. Their research spans multiple fields within medicine and biomedical sciences, with a particular focus on hematology, oncology, genetics, and immunology.

The scientist's work prominently covers several key topics:

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Mast cells and histamine
  • Melanin and skin pigmentation
  • Chronic Lymphocytic Leukemia Research
  • Cancer Immunotherapy and Biomarkers

Philip M. Kluin has contributed to research published in a variety of academic journals. Frequent publication venues include:

  • Blood
  • Blood Advances
  • The Journal of Allergy and Clinical Immunology In Practice
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • International Journal of Laboratory Hematology

Several of their recent papers illustrate the scope of their research. These include:

  • Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations (2021, Blood)
  • Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21) (2021, Blood Advances)
  • Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group (2022, The Journal of Allergy and Clinical Immunology In Practice)
  • Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features (2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin)
  • Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure (2020, International Journal of Laboratory Hematology)

Frequent co-authors collaborating with Philip M. Kluin include:

  • Peter Valent
  • Thomas Kielsgaard Kristensen
  • Tracy I. George
  • Wolfgang R. Sperr
  • Cem Akin

Their body of work reflects substantial engagement with both clinical and molecular aspects of hematologic malignancies and immune-related disorders. This includes investigation into diagnostic standards, molecular alterations, and treatment challenges associated with various blood cancers and systemic pathologies.

Philip M. Kluin's research contributes to advancing understanding in diverse but interconnected topics within medicine, including the genetics of blood disorders, pathology, and immune biomarkers relevant to cancer therapy and disease prognosis.

Best Publications

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • Double-hit B-cell lymphomas

    Sietse M. Aukema;Reiner Siebert;Ed Schuuring;Gustaaf W. van Imhoff

  • Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

    P. P. Tak;T. J. M. Smeets;M. R. Daha;P. M. Kluin

  • Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma

    M.H.H. Kramer;J. Hermans;E. Wijburg;K. Philippo

  • Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.

    P P Tak;P C Taylor;F C Breedveld;T J Smeets

  • Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.

    Markus Tiemann;Carsten Schrader;Wolfram Klapper;Martin H. Dreyling

  • Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO–EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers

    Nancy J. Senff;Juliette J. Hoefnagel;Patty M. Jansen;Maarten H. Vermeer

  • Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

    P. A. S. Evans;Ch Pott;P. J. T. A. Groenen;G. Salles

  • Involvement of the CCND1 gene in hairy cell leukemia

    C J de Boer;Johanna Kluin-Nelemans;E Dreef;M G Kester

  • Response to interferon alfa-2b in a patient with systemic mastocytosis.

    Hanneke C. Kluin-Nelemans;Joop H. Jansen;Henk Breukelman;Bert G Wolthers

  • Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

    Annuska M. Glas;Laurent Knoops;Leonie Delahaye;Marie Jose Kersten

  • Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

    Annuska M Glas;Marie José Kersten;Leonie J M J Delahaye;Anke T Witteveen

  • Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

    Sietske A. Riemersma;Ekaterina S. Jordanova;Roelandt F. J. Schop;Katja Philippo

  • Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.

    Marcel W Bekkenk;Maarten H Vermeer;Patty M Jansen;Ariënne M W van Marion

  • Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis

    P. P. Tak;P. A. Van Der Lubbe;A. Cauli;M. R. Daha

  • Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge

    E G Boerma;R Siebert;P M Kluin;Michael Baudis

  • Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome

    J. Pijpe;Warner Kalk;J. E. van der Wal;Arjan Vissink

  • Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma

    C. J. De Boer;E. Schuuring;E. Dreef;G. Peters

Frequent Co-Authors

Ed Schuuring
Ed Schuuring University Medical Center Groningen
Anke van den Berg
Anke van den Berg University Medical Center Groningen
Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen
Reiner Siebert
Reiner Siebert University of Ulm
Steven T. Pals
Steven T. Pals University of Amsterdam
Klaas Kok
Klaas Kok University of Groningen
Sibrand Poppema
Sibrand Poppema Sunway University
Edo Vellenga
Edo Vellenga University Medical Center Groningen
Ekaterina S. Jordanova
Ekaterina S. Jordanova Vrije Universiteit Amsterdam
Miguel-Angel Perales
Miguel-Angel Perales Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary career pathways in healthcare can broaden your horizons while studying Medicine in the USA. The growing demand for nurses and healthcare leaders makes online degrees an appealing option for many students.

Many consider advancing their education with specialized programs, such as phd nursing programs, which offer flexibility and open doors to research or academic careers. For registered nurses looking to boost their credentials, enrolling in one of the cheapest accredited online rn to bsn programs is a cost-effective way to expand job opportunities and increase earning potential.

Non-nurses interested in entering the profession may find entry level msn programs online a fast-track to advanced nursing roles—all without a prior nursing background. If you're concerned about admissions competitiveness, research whats the easiest nursing program to get into? for flexible pathway options that fit your academic profile.

Pursuing these online degrees not only enhances your medical knowledge, but also provides diverse career paths in today's dynamic healthcare landscape.

Best Scientists Citing Philip M. Kluin

Trending Scientists

Recently Published Articles